Compare PD & KTTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PD | KTTA |
|---|---|---|
| Founded | 2009 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 5.3M |
| IPO Year | 2019 | 2021 |
| Metric | PD | KTTA |
|---|---|---|
| Price | $12.87 | $1.15 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 1 |
| Target Price | ★ $17.70 | $3.00 |
| AVG Volume (30 Days) | 3.2M | ★ 21.6M |
| Earning Date | 11-25-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 1.63 | N/A |
| Revenue | ★ $489,207,000.00 | N/A |
| Revenue This Year | $8.21 | N/A |
| Revenue Next Year | $4.33 | N/A |
| P/E Ratio | $7.98 | ★ N/A |
| Revenue Growth | ★ 7.01 | N/A |
| 52 Week Low | $11.13 | $0.28 |
| 52 Week High | $20.57 | $3.85 |
| Indicator | PD | KTTA |
|---|---|---|
| Relative Strength Index (RSI) | 41.28 | 59.11 |
| Support Level | $11.55 | $1.09 |
| Resistance Level | $13.30 | $1.32 |
| Average True Range (ATR) | 0.48 | 0.23 |
| MACD | 0.12 | 0.01 |
| Stochastic Oscillator | 80.92 | 40.76 |
PagerDuty Inc is a digital operations management platform that manages urgent and mission-critical work for a modern, digital business. Its PagerDuty Operations Cloud combines artificial intelligence (AI) operations (AIOps), automation, customer service operations, and incident management with a generative AI assistant to create a flexible, resilient, and scalable platform to protect revenue and improve customer experience, improve operational efficiency, and mitigate the risk of operational failures. The company generates revenue predominantly from cloud-hosted software subscription fees and term-license software subscription fees. Geographically, the firm derives a majority of its revenue from the United States and the rest from International markets.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).